Clinical trial
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the…
NCT00293930 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00293930 |
|---|---|
| Title | A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma US, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Tacrolimus |
| Enrollment | 645 |
| Completion | Nov 1, 2006 |
| First posted | Feb 20, 2006 |
| Last update posted | Dec 24, 2007 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: